Ocular Inflammation Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: OE39A664EACAEN
Market Monitor Global

Abstracts

Ocular inflammation is a component of eye surgery, sometimes leading to its complications, such as macular cystoid edema, and often being targeted by pharmacologic therapy or less invasive surgical procedures.

This report contains market size and forecasts of Ocular Inflammation Therapeutics in Global, including the following market information:

Global Ocular Inflammation Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ocular Inflammation Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ocular Inflammation Therapeutics include Allergan, Cipla, Pfizer, Novartis, Bausch Health, Alimera Sciences, Akorn, Abbvie and Eyegate Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ocular Inflammation Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ocular Inflammation Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ocular Inflammation Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Corticosteroids
• Antibiotics
• Monoclonal Antibodies
• Immunosuppressant
• Other

Global Ocular Inflammation Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ocular Inflammation Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Drug Stores
• Hospital Pharmacies
• Online Pharmacies

Global Ocular Inflammation Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ocular Inflammation Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ocular Inflammation Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ocular Inflammation Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Cipla
• Pfizer
• Novartis
• Bausch Health
• Alimera Sciences
• Akorn
• Abbvie
• Eyegate Pharmaceuticals
• pSivida Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ocular Inflammation Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ocular Inflammation Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OCULAR INFLAMMATION THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Ocular Inflammation Therapeutics Market Size: 2021 VS 2028
2.2 Global Ocular Inflammation Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ocular Inflammation Therapeutics Players in Global Market
3.2 Top Global Ocular Inflammation Therapeutics Companies Ranked by Revenue
3.3 Global Ocular Inflammation Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Ocular Inflammation Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ocular Inflammation Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ocular Inflammation Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Ocular Inflammation Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ocular Inflammation Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ocular Inflammation Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Corticosteroids
  4.1.3 Antibiotics
  4.1.4 Monoclonal Antibodies
  4.1.5 Immunosuppressant
  4.1.6 Other
4.2 By Type - Global Ocular Inflammation Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Ocular Inflammation Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Ocular Inflammation Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ocular Inflammation Therapeutics Market Size, 2021 & 2028
  5.1.2 Drug Stores
  5.1.3 Hospital Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Ocular Inflammation Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Ocular Inflammation Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Ocular Inflammation Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ocular Inflammation Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Ocular Inflammation Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Ocular Inflammation Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Ocular Inflammation Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ocular Inflammation Therapeutics Revenue, 2017-2028
  6.3.2 US Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.3.3 Canada Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Ocular Inflammation Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ocular Inflammation Therapeutics Revenue, 2017-2028
  6.4.2 Germany Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.4.3 France Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.4.5 Italy Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.4.6 Russia Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Ocular Inflammation Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ocular Inflammation Therapeutics Revenue, 2017-2028
  6.5.2 China Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.5.3 Japan Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.5.6 India Ocular Inflammation Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ocular Inflammation Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Ocular Inflammation Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ocular Inflammation Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.7.3 Israel Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Ocular Inflammation Therapeutics Market Size, 2017-2028
  6.7.5 UAE Ocular Inflammation Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Ocular Inflammation Therapeutics Major Product Offerings
  7.1.4 Allergan Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Allergan Key News
7.2 Cipla
  7.2.1 Cipla Corporate Summary
  7.2.2 Cipla Business Overview
  7.2.3 Cipla Ocular Inflammation Therapeutics Major Product Offerings
  7.2.4 Cipla Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Cipla Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Ocular Inflammation Therapeutics Major Product Offerings
  7.3.4 Pfizer Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Ocular Inflammation Therapeutics Major Product Offerings
  7.4.4 Novartis Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Bausch Health
  7.5.1 Bausch Health Corporate Summary
  7.5.2 Bausch Health Business Overview
  7.5.3 Bausch Health Ocular Inflammation Therapeutics Major Product Offerings
  7.5.4 Bausch Health Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Bausch Health Key News
7.6 Alimera Sciences
  7.6.1 Alimera Sciences Corporate Summary
  7.6.2 Alimera Sciences Business Overview
  7.6.3 Alimera Sciences Ocular Inflammation Therapeutics Major Product Offerings
  7.6.4 Alimera Sciences Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Alimera Sciences Key News
7.7 Akorn
  7.7.1 Akorn Corporate Summary
  7.7.2 Akorn Business Overview
  7.7.3 Akorn Ocular Inflammation Therapeutics Major Product Offerings
  7.7.4 Akorn Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Akorn Key News
7.8 Abbvie
  7.8.1 Abbvie Corporate Summary
  7.8.2 Abbvie Business Overview
  7.8.3 Abbvie Ocular Inflammation Therapeutics Major Product Offerings
  7.8.4 Abbvie Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Abbvie Key News
7.9 Eyegate Pharmaceuticals
  7.9.1 Eyegate Pharmaceuticals Corporate Summary
  7.9.2 Eyegate Pharmaceuticals Business Overview
  7.9.3 Eyegate Pharmaceuticals Ocular Inflammation Therapeutics Major Product Offerings
  7.9.4 Eyegate Pharmaceuticals Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Eyegate Pharmaceuticals Key News
7.10 pSivida Corporation
  7.10.1 pSivida Corporation Corporate Summary
  7.10.2 pSivida Corporation Business Overview
  7.10.3 pSivida Corporation Ocular Inflammation Therapeutics Major Product Offerings
  7.10.4 pSivida Corporation Ocular Inflammation Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 pSivida Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ocular Inflammation Therapeutics Market Opportunities & Trends in Global Market
Table 2. Ocular Inflammation Therapeutics Market Drivers in Global Market
Table 3. Ocular Inflammation Therapeutics Market Restraints in Global Market
Table 4. Key Players of Ocular Inflammation Therapeutics in Global Market
Table 5. Top Ocular Inflammation Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ocular Inflammation Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ocular Inflammation Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ocular Inflammation Therapeutics Product Type
Table 9. List of Global Tier 1 Ocular Inflammation Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ocular Inflammation Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ocular Inflammation Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ocular Inflammation Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ocular Inflammation Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ocular Inflammation Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ocular Inflammation Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ocular Inflammation Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Ocular Inflammation Therapeutics Product Offerings
Table 32. Allergan Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Cipla Corporate Summary
Table 34. Cipla Ocular Inflammation Therapeutics Product Offerings
Table 35. Cipla Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Ocular Inflammation Therapeutics Product Offerings
Table 38. Pfizer Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Ocular Inflammation Therapeutics Product Offerings
Table 41. Novartis Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Bausch Health Corporate Summary
Table 43. Bausch Health Ocular Inflammation Therapeutics Product Offerings
Table 44. Bausch Health Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Alimera Sciences Corporate Summary
Table 46. Alimera Sciences Ocular Inflammation Therapeutics Product Offerings
Table 47. Alimera Sciences Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Akorn Corporate Summary
Table 49. Akorn Ocular Inflammation Therapeutics Product Offerings
Table 50. Akorn Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Abbvie Corporate Summary
Table 52. Abbvie Ocular Inflammation Therapeutics Product Offerings
Table 53. Abbvie Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Eyegate Pharmaceuticals Corporate Summary
Table 55. Eyegate Pharmaceuticals Ocular Inflammation Therapeutics Product Offerings
Table 56. Eyegate Pharmaceuticals Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. pSivida Corporation Corporate Summary
Table 58. pSivida Corporation Ocular Inflammation Therapeutics Product Offerings
Table 59. pSivida Corporation Ocular Inflammation Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ocular Inflammation Therapeutics Segment by Type in 2021
Figure 2. Ocular Inflammation Therapeutics Segment by Application in 2021
Figure 3. Global Ocular Inflammation Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ocular Inflammation Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ocular Inflammation Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ocular Inflammation Therapeutics Revenue in 2021
Figure 8. By Type - Global Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ocular Inflammation Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ocular Inflammation Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cipla Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bausch Health Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Alimera Sciences Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Akorn Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Abbvie Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Eyegate Pharmaceuticals Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. pSivida Corporation Ocular Inflammation Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)